Bhaskar Pallerla

Title: Bhaskar Pallerla: Innovator in Pharmaceutical Formulations

Introduction

Bhaskar Pallerla is a notable inventor based in Baroda, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of 3 patents to his name, Pallerla's work focuses on enhancing the stability and efficacy of pharmaceutical compounds.

Latest Patents

One of Bhaskar Pallerla's latest patents is a parenteral unit dosage form of dihydroergotamine. This invention comprises an aqueous solution of dihydroergotamine or a pharmaceutically acceptable salt as the sole active ingredient. It includes one or more pH adjusting agents and optionally one or more co-solvents. The pH of the aqueous solution is designed to contain substantially lower amounts of impurities compared to solutions with a pH of 4.0 or less, especially when stored under specific conditions. This innovation aims to improve the stability of the drug when stored at 25°C and 60% relative humidity for at least three months.

Career Highlights

Throughout his career, Bhaskar Pallerla has worked with prominent companies in the pharmaceutical industry, including Sun Pharmaceutical Industries Limited and Pharmaceutical Industries Limited. His experience in these organizations has contributed to his expertise in drug formulation and development.

Collaborations

Some of his notable coworkers include Alpesh Goyani and Deepak Singodia. Their collaboration has likely played a role in advancing their collective work in pharmaceutical innovations.

Conclusion

Bhaskar Pallerla's contributions to pharmaceutical formulations demonstrate his commitment to improving drug delivery systems. His innovative patents reflect a deep understanding of the complexities involved in pharmaceutical science.